Obsessive-Compulsive Disorder – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Obsessive-Compulsive Disorder – Drugs In Development, 2024 report and make more profitable business decisions.
Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that lead the patient to perform repetitive behaviors (compulsions). Symptoms include having repeated thoughts or mental images about certain things, such as fears of germs, dirt, intruders, acts of violence, or hurting loved ones; and doing the same rituals over and over, such as washing hands, locking and unlocking doors, counting, keeping unneeded items, or repeating the same steps again and again. Risk factors include family history. Treatment includes antidepressants and psychiatric medications.
The Obsessive-Compulsive Disorder drugs in development market research report provide comprehensive information on the therapeutics under development for Obsessive-Compulsive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Obsessive-Compulsive Disorder | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 9 molecules, with 9 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Obsessive-Compulsive Disorder therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Obsessive-Compulsive Disorder pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Obsessive-Compulsive Disorder treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Amorsa Therapeutics IncBiogen Inc
Biohaven Ltd
Ceruvia Lifesciences LLC
Evecxia Therapeutics Inc
Omeros Corp
PharmaTher Holdings Ltd
Phytecs
Rugen Therapeutics R&D (Shanghai) Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Obsessive-Compulsive Disorder reports